Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: United States Clear all

895 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200014
200110
200211
200314
200416
200517
200616
200728
200824
200931
201021
201127
201221
201329
201427
201549
201648
201741
201847
201946
202048
202157
202255
202348
202456
202544
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed420
Terminated232
Recruiting112
Active, not recruiting83
Unknown status24
Withdrawn11
Not yet recruiting8
Suspended4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)46
Pfizer37
Novartis Pharmaceuticals26
Eli Lilly and Company25
AstraZeneca21
AbbVie18
M.D. Anderson Cancer Center18
Roswell Park Cancer Institute17
Memorial Sloan Kettering Cancer Center14
Bayer11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung895
Lung Neoplasms250
Colorectal Neoplasms186
Melanoma162
Neoplasms161
Ovarian Neoplasms142
Squamous Cell Carcinoma of Head and Neck137
Breast Neoplasms135
Carcinoma, Renal Cell124
Neoplasm Metastasis113

Trials

Showing 1 to 25 of 895. Each trial links to its page on Pharma Observatory.

795 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.